搜尋結果
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 7 日前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
China’s TikTok Shop sellers brace for an uncertain future
South China Morning Post· 5 日前Other cross-border merchants interviewed by the South China Morning Post are more certain. ...
Greater Bay Area: Chinese cross-border e-commerce firms fuel warehouse demand
South China Morning Post· 4 日前Logistics property in the bay area “bucked the headwinds” of a surge in new supply, said Silvia ...
Harman aims to expand in Chinese market
China Daily· 4 日前Driven by an automobile production boom in China, Harman International, a United States-based ...